Atrial Fibrillation (AF) is a prevalent heart rhythm disorder characterized by irregular and often rapid heartbeats. In this condition, the heart's upper chambers (atria) quiver or flutter, disrupting the normal electrical impulses that coordinate heartbeats. As a result, the heart may not pump blood effectively, leading to potential complications such as blood clots, stroke, or heart failure. AF can affect individuals of any age, but it becomes more common with age, and certain factors such as hypertension, diabetes, and heart disease can elevate the risk. Symptoms may include palpitations, fatigue, dizziness, and shortness of breath. Timely diagnosis and management of Atrial Fibrillation are crucial to mitigate associated risks and enhance the quality of life for those affected. Treatment strategies often involve medications, lifestyle modifications, and in some cases, medical procedures to restore or regulate the heart's rhythm. As research continues to advance, a better understanding of the mechanisms behind AF and innovative treatment options offer hope for improved outcomes and enhanced patient care
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India